Injecting semaglutide in the morning could be advantageous for those who experience gastrointestinal side effects
EGFR tyrosine kinase inhibitor-associated interstitial lung disease during the Coronavirus Disease 2019 Pandemic
You can start with small changes first, like taking the stairs and not the elevator or on your breaks walking a little, also stretching to relax the muscles a bit
doi: 10.1038/sj.ijo.0801083 Summary Keywords Prader-Willi syndrome, obesity, GLP-1 receptor agonist, semaglutide, metabolic surgery Citation Koceva A, Mleku Kozamernik K, Jane A, Herman R, Ferjan S and Jensterle M (2025) Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
Steve Midway is a professor at Louisiana State University